5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique-Reference-Cited by-同舟云学术

5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique

Published:2023-07 Issue:3 Volume:82 Page:183-195
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Stone Gregg W.,Kereiakes Dean J.,Gori Tommaso,Metzger D. Christopher,Stein Bernardo,Erickson Matthew,Torzewski Jan,Kabour Ameer,Piegari Guy,Cavendish Jeffrey,Bertolet Barry,Stockelman Kelly A.^ORCID,West Nick E.J.,Ben-Yehuda Ori,Choi James W.,Marx Steven O.,Spertus John A.,Ellis Stephen G.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Stent-related adverse events >1 year after percutaneous coronary intervention;Madhavan;J Am Coll Cardiol,2020

2. Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation;Yamaji;Circ Cardiovasc Interv,2010

3. Bioresorbable vascular scaffolds for coronary revascularization;Kereiakes;Circulation,2016

4. The state of the Absorb bioresorbable scaffold: consensus from an expert panel;Bangalore;J Am Coll Cardiol Intv,2017

5. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent;American Heart Journal;2024-11

2. Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds—insights from the EVERBIO-2 trial;Frontiers in Cardiovascular Medicine;2024-09-10

3. Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial;American Heart Journal;2024-09

4. Challenges and Advances in Interventional Cardiology for Coronary Artery Disease Management;Medicina;2024-08-15

5. Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis;JACC: Cardiovascular Interventions;2024-08